Guangdong True Health, Zhejiang Laifual, Hangzhou Qiandaohu jump in HK debut

Guangdong True Health Medical Technology Development

30/06/2026 06:17

** Guangdong True Health Medical Technology Development 2697.HK stock surges 204.3% to HK$384 on HK debut, vs 1.2% drop in Hang Seng Index .HSI
** Surgical robots developer's HK public offer 1,790.4x subscribed; international tranche 2.2x; raised HK$449.3 mln ($57.29 mln) for R&D, commercialization
** Separately, robotic components maker Zhejiang Laifual Drive 3952.HK rises up to 13.1% from HK$85.5 offer price; HK public offering 4,571.99x subscribed, international 7.89x
** Caviar producer Hangzhou Qiandaohu Xunlong Sci-tech 6715.HK jumps 47% from the HK$75.50 offer price after raising HK$1.23 bln in global offering
** Jiangxi Institute of Biological Products 6915.HK drops 34.8% from offer price after human tetanus antitoxin producer raised HK$405.8 mln in global offering 
($1 = 7.8425 Hong Kong dollars)

(Reporting by Donny Kwok)
((donny.kwok@thomsonreuters.com))